Journal of Autoimmunity

Article	Citations
Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats	187
Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases	166
Striatin-3 is a human autoantigen but it is not associated with the S-phase G2 nuclear antigen (SG2NA) staining pattern	164
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis	137
HNF4α, SP1 and c-myc are master regulators of CNS autoimmunity	128
Advances in SLE classification criteria	125
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial	117
Immunological and fibrotic profiling in the NOD.c3c4 murine model of autoimmune cholangitis	111
Ectopic CD4+ T cells in choroid plexus mediate neuropsychiatric lupus symptoms in mice via interferon-γ induced microglia activation	104
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients	92
Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis	91
Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis	87
Editorial Board	72
PAD2-mediated citrullination of MBP and early myelin destabilization in multiple sclerosis	70
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations	70
Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: A comprehensive systematic analysis and modelling study	69
Autoimmune associated HLAs and T cell autoantigens exhibit common patterns across several autoimmune diseases	67
Tfh cell-derived small extracellular vesicles exacerbate the severity of collagen-induced arthritis by enhancing B-cell responses	65
Lupus nephritis: new progress in diagnosis and treatment	64
Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations	63
Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome	63
Editorial Board	60
LAT1 enables T cell activation under inflammatory conditions	54
Editorial Board	54
Sunscreen use associated with elevated prevalence of anti-nuclear antibodies in U.S. adults	53

Free water in the hippocampal cingulum as a Radiomic biomarker for Identifying inflammatory neuropsychiatric Lupus: A cross-sectional case-control study	52
Editorial Board	51
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow	51
Mitochondrial dysfunction is a potential key mechanism for atherosclerosis predisposition in patients with systemic lupus erythematosus	50
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies	48
Glycobiology of psoriasis: A review	47
Proinflammatory CD20+CD3+ T cells as a potential driver of macrophage reprogramming in rheumatoid arthritis	42
Antigenic mimicry – The key to autoimmunity in immune privileged organs	42
Deciphering Sjögren's disease: New insights and perspectives extend from advanced omics approaches and immunology	40
Cellular communication network factor 3 contributes to the pathological process of rheumatoid arthritis through promoting cell senescence and osteoclastogenesis in the joint	40
Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes	40
Interferon signatures fuel B cell hyperactivity and plasmablast expansion in systemic lupus erythematosus	39
FAPI PET/CT for tracking disease trajectory in myositis-related interstitial lung disease	39
Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation	38
Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice	36
Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis	35
Anti-annexin A4 antibody as a biomarker for desquamative interstitial pneumonia	35
The complement system and human autoimmune diseases	34
Editorial Board	33
External and internal exposome as triggers of biological signalling in systemic sclerosis – A narrative synthesis	33
Antigen-specific immune reactions by expanded CD8+ T cell clones from HLA-B*27-positive patients with spondyloarthritis	32
Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathy	31
Single-cell sequencing of the retina shows that LDHA regulates pathogenesis of autoimmune uveitis	31
Autoimmune markers and vascular immune deposits in Finkelstein-Seidlmayer vasculitis: Systematic literature review	31
Perinatal use of targeted synthetic DMARDs and maternal-neonatal outcomes in autoimmune disease: A population-based cohort study	31
Editorial Board	30
Differential changes in the gut microbiota between extrinsic and intrinsic atopic dermatitis	30
Peripheral immune profiling highlights a dynamic role of low-density granulocytes in myasthenia gravis	29
Clinical utility of measuring CD4+ T follicular cells in patients with immune dysregulation	29
Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study	29
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach	29
Familial patterns of alopecia areata: A systematic review and meta-analysis	29
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target	28
Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus	28
The role of gut flora-driven Th cell responses in preclinical rheumatoid arthritis	27
Pregnancy-related complications in systemic lupus erythematosus	27
The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis	27
Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS proje	27
Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice	27
Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis	27
Coronavirus disease 2019, vaccination against coronavirus and immunoglobulin A-mediated diseases: systematic literature review	27
Environmental exposures as risk factors for idiopathic inflammatory myopathies	26
Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study	26
Evaluation of the mycophenolate mofetil–rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)	26
Altered lipid metabolism in synovial fibroblasts of individuals at risk of developing rheumatoid arthritis	26
LAMP3-mediated epithelial-mesenchymal transition promotes the invasion and excessive proliferation of fibroblast-like synoviocytes in rheumatoid arthritis	26
Functional metagenomic analysis reveals potential inflammatory triggers associated with genetic risk for autoimmune disease	26
Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicity	26
T cell aging as a risk factor for autoimmunity	26
Alternate splicing converts human CD137 from costimulatory to immunosuppressive function	25

Editorial Board	25
Temporal trajectories and DMARD therapy retention of rheumatoid arthritis patients with different autoimmune and inflammatory comorbidity profiles: a retrospective analysis	25
Recent advances in cutaneous lupus	25
Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases	24
Significance of anti-transcobalamin receptor antibodies in cutaneous arteritis revealed by proteome-wide autoantibody screening	24
Interleukin 17-producing C-C motif chemokine receptor 6 + conventional CD4+ T cells are arthritogenic in an animal model of spondyloarthritis	24
Extracellular vesicle autoantibodies	24
Pathophysiological effects of long COVID-19 (auto)antibodies on fertility	24
Methotrexate and low-dose prednisone in idiopathic retroperitoneal fibrosis: a randomised clinical trial	23
Acquired susceptibility to autoimmune diseases in pediatric patients with Escherichia coli infection: A population-matched retrospective cohort study	23
Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL/lpr mice	23
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome	22
Pro-fibrotic effect of the susceptible gene PCSK5 in vascular fibrosis of Takayasu arteritis via TGF-β and SMAD3 signaling pathway activation	22
Preliminary safety and efficacy of relmacabtagene autoleucel (relma-cel) in adults with moderately to severely active systemic lupus erythematosus: a phase I dose-escalation study	22
Exploration of new biomarkers for rheumatoid arthritis based on plasma proteomics and transcriptome integrated with genome-wide Mendelian randomization	22
Gut microbiota in systemic lupus erythematosus: A fuse and a solution	22
Interleukin-15 is a hair follicle immune privilege guardian	22
Randomized controlled single-center clinical trial of high-intensity interval training in patients with systemic lupus erythematosus	22
2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis	21
Natural IgG protects against early dissemination of vesicular stomatitis virus	21
Pin1 maintains the effector program of pathogenic Th17 cells in autoimmune neuroinflammation	21
Genetic and pharmacological targeting of GSDMD ameliorates systemic inflammation in macrophage activation syndrome	21
JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study	21
T follicular helper cells in autoimmune diseases	21
Physical work demands and risk of rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus. A Danish longitudinal cohort study	20
Comprehensive description of adult-onset Still's disease after COVID-19 vaccination	20
VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder – A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape	20
Multi-omics study reveals different pathogenesis of the generation of skin lesions in SLE and IDLE patients	19
Editorial Board	19
Application of laboratory models for sarcoidosis research	19
Acute-type acquired hemophilia A after COVID-19 mRNA vaccine administration: A new disease entity?	19
Fecal microbiota transplantation in the treatment of systemic lupus erythematosus: What we learnt from the explorative clinical trial	19
Altered glucose metabolism in B cells: Implications for the pathogenesis and treatment of autoimmune diseases	18
Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitis	18
CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus	18
Autoimmune diseases and the risk of bladder cancer: A Mendelian randomization analysis	18
Association between age groups and relapse of type 1 autoimmune pancreatitis: a large-scale retrospective cohort study	18
Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells	18
A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile	18
Neonatal total parenteral nutrition and the risk of childhood autoimmune diseases: A nationwide population-based study of 2.3 million children	18
Chimeric antigen receptor T cell therapy: a new frontier therapeutic landscape in autoimmune diseases	17
Treatment of mixed connective tissue disease: A multicenter retrospective study	17
Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases	17
Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets	17
PD1+ innate lymphoid cells 3 predict JAK-dependent inflammation in rheumatoid arthritis	17
Vascular effects of achieving low disease activity in axial spondyloarthritis – A 2-year prospective treat-to-target study	17
Poorer survival for patients with inflammatory arthritis treated with immune checkpoint inhibitors for melanoma	17
Autophagy pathways in autoimmune diseases	16
Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease	16
PD-1 antibody interactions with Fc gamma receptors enable PD-1 agonism to inhibit T cell activation – therapeutic implications for autoimmunity	16
Amelioration of immunoglobulin A vasculitis by suppression of the pathological expansion of T follicular helper 17 cells	16
Outcome and prognosis of isolated carotid vasculitis	16
Sonic hedgehog promotes synovial inflammation and articular damage through p38 mitogen-activated protein kinase signaling in experimental arthritis	16
Regulatory T cells effectively downregulate the autoimmune anti-MPO response and ameliorate anti-MPO induced glomerulonephritis in mice	16
Developmental drugs for sarcoidosis	16
Autoimmune hepatitis following COVID-19 vaccination	16
Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database	16
Repeated immunization with ATRA-containing liposomal adjuvant transdifferentiates Th17 cells to a Tr1-like phenotype	16
Cognitive dysfunction in SLE: An understudied clinical manifestation	16
The double-edged sword role of copper in rheumatoid arthritis: Mechanisms, therapeutics, and challenges	16
Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis	16
Comparative effectiveness of preventive treatment with dimethyl fumarate-loaded solid lipid nanoparticles and oral dimethyl fumarate in a mouse model of multiple sclerosis	16
Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for Rheumatology	15
Runx3 instructs Aire+ mTEC development, TSA gene expression, and central tolerance	15
Editorial Board	15
mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency	15
Pre-existing conditions associated with post-acute sequelae of COVID-19	15
Pathogenicity of functionally activated PD-1+CD8+ cells and counterattacks by muscular PD-L1 through IFNγ in myositis	15
Sera from patients with dermatomyositis and antisynthetase syndrome mediate muscle weakness, impair mitochondrial respiration and induce local cytokine production in muscle tissue	15
PPARG-mediated autophagy activation alleviates inflammation in rheumatoid arthritis	15
Extracellular microRNAs induce dendritic cell-dependent joint inflammation and potentiate osteoclast differentiation via TLR7/8 engagement	15
A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus	15
What's in a name? – juxtaposing T follicular, peripheral and resident helper cells in B cell-driven autoimmune diseases	15
B cell-specific mAb–siRNA conjugates improve experimental myasthenia	15
Interpretation of the association between thyroid peroxidase antibodies and thyroid function during pregnancy: An individual participant data meta-analysis	14
Editorial Board	14
Transcriptomic analyses of lung tissues reveal key genes associated with progression of systemic sclerosis-interstitial lung disease (SSc-ILD)	14
Peripheral helper T cells in human diseases	14
Diversity and function of regulatory T cells in health and autoimmune diseases	14
Anti-retinal immune response in sarcoid uveitis: A potential role for PCLO as an antigenic target	14

Autoimmune modulation of immune-endocrine-metabolic regulation of ovarian reserve: A cohort study of 803 women	14
Editorial Board	14
Flagellin-specific human CAR Tregs for immune regulation in IBD	14
Loss of function of XBP1 splicing activity of IRE1α favors B cell tolerance breakdown	14
Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study	14
Editorial Board	14
TIGIT-Fc fusion protein alleviates murine lupus nephritis through the regulation of SPI-B-PAX5-XBP1 axis-mediated B-cell differentiation	14
Trained innate immunity in response to nuclear antigens in systemic lupus erythematosus	14
Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments	14
K2P2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathies	13
Prioritization of infectious epitopes for translational investigation in type 1 diabetes etiology	13
Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation	13
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study	13
SARS-CoV-2 mRNA vaccines do not worsen autoimmunity in patients with autoimmune liver diseases	13
Treatment outcomes stratified by interferon profile and autoantibodies in rheumatoid arthritis	13
Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice	13
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients	13
Sex differences in biomarkers and biologic mechanisms in psoriatic diseases and spondyloarthritis	12
Passive maternal immunity in children born to women with systemic autoimmune rheumatic disease – A case-control study	12
Evolving understandings for the roles of non-coding RNAs in autoimmunity and autoimmune disease	12
Melatonin synergistically potentiates the effect of methylprednisolone on reducing neuroinflammation in the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis	12
Immune complexome analysis of a rich variety of serum immune complexes identifies disease-characteristic immune complex antigens in systemic sclerosis	12
WTAP promotes the progression of ulcerative colitis by silencing the expression of CES2 through m6A modification	12
Autoantibodies against the NineTeen complex and U5 RNP in systemic sclerosis	12
Effects of fecal microbiota transplant on DNA methylation in patients with systemic lupus erythematosus	12
High throughput screening identifies repurposable drugs for modulation of innate and acquired immune responses	12
How early-life adversity affects the risk of pediatric-onset immune-mediated inflammatory disease	12
Targeted protein degradation in autoimmune diseases: from mechanisms to therapeutic breakthroughs	12
Perivascular B cells link intestinal angiogenesis to immunity and to the gut-brain axis during neuroinflammation	12
Compositional and functional aberrance of the gut microbiota in treatment-naïve patients with primary Sjögren's syndrome	12
The risk of cancer in pediatric-onset immune-mediated inflammatory diseases – A nationwide study	12
Cytokine receptor γc effectuates the generation of proinflammatory innate CD8 T cells by non-classical MHC-I molecules	12
Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy	12
Novel and unique rheumatoid factors cross-react with viral epitopes in COVID-19	12
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis	11
Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors	11
Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritis	11
Signal responses to neutral TSH receptor antibody – A cycle of damage in the pathophysiology of Graves’ disease	11
Molecular signature of neutrophil extracellular trap mediating disease module in idiopathic inflammatory myopathy	11
Tlr9 expression protects against Tlr7-dependent exocrine gland and systemic disease manifestations in primary Sjögren's disease in a sex-biased manner	11
Control of naive and effector CD4 T cell receptor repertoires by rheumatoid-arthritis-risk HLA alleles	11
COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study	11
Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application	11
Cognition following chimeric antigen receptor T-cell therapy: A systematic review	11
SB431542 alleviates lupus nephritis by regulating B cells and inhibiting the TLR9/TGFβ1/PDGFB signaling	11
The concept of severity in psoriatic arthritis: a scoping review of the literature	11
Identification of a novel PDC-E2 epitope in primary biliary cholangitis: Application for engineered Treg therapy	11
Editorial Board	11
Multiple sclerosis-associated EBNA2 variants influence the response to peginterferon beta-1a therapy	11
ETS-1 facilitates Th1 cell-mediated mucosal inflammation in inflammatory bowel diseases through upregulating CIRBP	11
Salivary gland epithelial cell in Sjögren's syndrome: Metabolic shift and altered mitochondrial morphology toward an innate immune cell function	11
miR-143-3p boosts extracellular vesicles to improve the dermal fibrosis of localized scleroderma	11
Soluble form of immune checkpoints in autoimmune diseases	10
PPAR-γ dysregulation links NF-κB activation and Nrf2-driven antioxidant responses in axial spondyloarthritis: A pilot study	10
CD72 is an inhibitory pattern recognition receptor that recognizes ribosomes and suppresses production of anti-ribosome autoantibody	10
Circulating T cells in sarcoidosis have an aberrantly activated phenotype that correlates with disease outcome	10
Circulating immune profile in granulomatosis with polyangiitis reveals distinct patterns related to disease activity	10
Sarcoidosis and its relation to other immune-mediated diseases: Epidemiological insights	10
Editorial Board	10
Conformational state of C-reactive protein is critical for reducing immune complex-triggered type I interferon response: Implications for pathogenic mechanisms in autoimmune diseases imprinted by type	10
The emerging role of BLyS/APRIL in autoimmune diseases: Biological characteristics, functions, and therapeutic potential	10
Old known and possible new biomarkers of ANCA-associated vasculitis	10
Isolation and characterisation of PR3-specific B cells and their immunoglobulin sequences	10
Inflammatory disease status and response to TNF blockade are associated with mechanisms of endotoxin tolerance	10
Fecal microbiota transplantation for the management of autoimmune diseases: Potential mechanisms and challenges	10
Renoprotective anti-CD45RB antibody induces B cell production in systemic lupus erythematosus based on single-cell RNA-seq analysis	10
Single-cell analysis highlights a population of Th17-polarized CD4+ naïve T cells showing IL6/JAK3/STAT3 activation in pediatric severe aplastic anemia	10
Interventional studies targeting the prodromal or preclinical phase of immune-mediated disease to benefit patient outcomes: a scoping review	10
Evaluation of minor labial salivary gland focus score in Sjögren's disease using deep learning: a tool for more efficient diagnosis and future tissue biomarker discovery	10
Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease	10
Caspase-10 affects the pathogenesis of primary biliary cholangitis by regulating inflammatory cell death	10
Advanced pulmonary sarcoidosis	10
Divergent regulatory T cell responses to high-dose methylprednisolone and tocilizumab in giant cell arteritis	10
Associations between domestic hard water exposure and incident psoriasis in adults: Insights from the UK Biobank cohort study	9
The immunomodulatory roles of the gut microbiome in autoimmune diseases of the central nervous system: Multiple sclerosis as a model	9
Extracellular vesicles released upon stimulation with antiphospholipid antibodies: An actual direct procoagulant mechanism or a new factor in the lupus anticoagulant paradox?	9
Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis	9
Engineered Treg cells: The heir to the throne of immunotherapy	9
Decoding CD4+ T cell transcriptome in giant cell arteritis: Novel pathways and altered cross-talk with monocytes	9
Editorial Board	9
Involvement of trained immunity during autoimmune responses	9
Exercise, autoimmune diseases and T-regulatory cells	9
Calprotectin and neurofilament serum levels correlate with treatment response in myasthenia gravis under intensified therapy–A pilot study	9
Infectious diseases, autoantibodies, and autoimmunity	9
Tissue-resident memory T cells: The key frontier in local synovitis memory of rheumatoid arthritis	9
Prior murine neurotropic coronavirus infection ameliorates experimental autoimmune encephalitis	9
Neuropsychiatric lupus erythematosus: Focusing on autoantibodies	9
Lung transplantation in pulmonary sarcoidosis	9
A framework for exclusion of alternative diagnoses in sarcoidosis	9
Endothelial cell-derived plasminogen activator inhibitor-1 potentiates thrombosis in antiphospholipid syndrome	9
The cancer-associated glycan polysialic acid is dysregulated in systemic sclerosis and is associated with fibrosis	9
Vasculopathy and vasculitis associated with levamisole-adulterated cocaine: a systematic review	9
Increased RNA editing sites revealed as potential novel biomarkers for diagnosis in primary Sjögren's syndrome	9
A novel subset of inflammation-related liver NK cells modulates immune responses in a murine model of primary biliary cholangitis	9
Alterations of fecal microbiome and metabolome in pemphigus patients	8